关于我们

Tianfeng Capital, headquartered in Zhongguancun, Beijing, was established in 2013 as an investment group focused on the life science and medical health industry. Centered around the principles of mutual trust and mutual benefit, we prioritize investor orientation and aim to create value through proactive value-added services. Our goal is to promote innovation and growth in the companies we invest in or plan to invest in, and help create excellent companies across various segments. As of the end of 2021, Tianfeng Capital has managed two RMB funds, one US dollar fund, and three project funds (SPVs).

At Tianfeng Capital, we adhere to the principles of project selection, centralized investment, and in-depth service. By the end of 2021, we had invested in a total of 12 projects, with one project listed on the Growth Enterprise Market (GEM) and another listed in the Hong Kong biotechnology sector (included in the Hang Seng Composite Index, Shenzhen-Hong Kong Stock Connect, and Shanghai-Hong Kong Stock Connect). Additionally, one project is expected to be listed on the GEM in 2022, and another is expected to be listed in the Hong Kong biotechnology sector between 2022 and 2023. Moreover, more than ten projects previously invested by the Tianfeng management team prior to the establishment of Tianfeng Capital have been successfully listed.

Tianfeng Capital currently operates offices throughout East and South China, where they are able to not only thoroughly research local investment opportunities but also support the expansion of funded businesses. We will work together with some of our limited partners on the specific project to invest in it in order to give long-term financial support for the growth of the business; in addition, we have a large network of connections and foundations for cooperation in the investment sector. In order to create a win-win situation, we are prepared to collaborate with peers and integrate resources to support the invested firms.

Company profile

Company philosophy

我们的优势

OUR ADVANTAGES

●
Leading value
●
Allocation of
●
Collaborative
●
Increase long-term value

Leading Value Discovery

For the projects invested in Round A, the following Round B and Round C have been invested by well-known funds, such as Hillhouse Capital, OrbiMed Capital, Lilly Asia Fund, etc

Resource Allocation

To provide consulting, support, and assistance to the invested enterprises by using available resources and brand influence from the general partners and limited partners. To support business owners with adequate resources, financial capital, and intellectual capital.

Collaborative industrial ecology

Build a cooperative value-added platform for invested and proposed projects, limited partners, related parties and Tianfeng, organically integrate ecosystem resources, and create upstream and downstream synergies in the industrial chain

Increase long-term value

The "finance+industry" double cycle model enables enterprises to make investment analysis, decision making and exit by using the financial method, to provide value-added services and management by using the industrial method, to continuously optimize the ecosystem, and to truly bring long-term value growth to both sides of industry and finance

Leading Value Discovery

Effectively use the resources and brand influence of the general partner and limited partners, continue to provide consulting, support and help to the invested enterprises, and be an entrepreneur friend integrating "smart capital+capital+resources"

Resource Allocation

Collaborative industrial ecology

Increase long-term value

我们的团队

OUR TEAM

With extensive knowledge of the big health industry, extensive investment and financing experience, and excellent analytical and decision-making skills, we can provide personalized services to invested enterprises.

Senior professional

We are skilled in identifying potential leaders in segmented sectors. And we can assist businesses in becoming clear market leaders through advanced management concepts and techniques and the empowerment of industrial resources.

Acute Insight

Rich industry expertise makes we simpler to build connection with businesses and gain their support. We can assist businesses to achieve value-added and identify the M&A integration prospects.

Industrial background

We have academic resources offered by Tsinghua University, Peking University, Central South University, and Sun Yat-sen University to support the development of the businesses.

Academic support

我们的荣誉

OUR HONOR

Tianfeng Healthcare Fund I, L.P. had outstanding results, placing third on the “Best Performing US Dollar Venture Capital Fund in Greater China” and eighth on the “Best Growth and M&A Venture Capital Fund in Asia Pacific” by the renowned private fund data platform PreQin.

We are based in Beijing, with roots in Zhongguancun, and work to cultivate top scientific and technology businesses. Considering our commitment to the advancement of research and development, we were elected as standing committee member of Zhongguancun Venture Capital Association.

We are also the sub-fund management organization of Beijing Science and Technology Innovation Fund.